Marina Salluzzi

Marina Salluzzi

Auto-generated profile, based on publicly available information

Marina Salluzzi

University of Calgary

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2007 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
LKLinda Ko
Linda Ko
MSMarina Salluzzi
Marina Salluzzi
RFRichard Frayne
Richard Frayne
MSMichael Smith
Michael Smith
Purpose To determine the true impact of dispersion upon cerebral blood flow (CBF) quantification by removing an algorithm implementation-induced systematic error. Materials and Methods The impact of dispersion on the arterial input function (AIF) between measurement and entry into the tissue of interest on CBF estimates was simulated assuming: 1) contralateral circulation flow that introduces a true arterial tissue delay (ATD)-related dispersive component; and 2) the presence of an arterial stenosis that disperses and shifts the AIF peak entering the tissue; increasing the apparent ATD relative to the original AIF. Results Previously reported CBF estimates for the stenosis dispersion model were found to be a mixture of true dispersive effects and an algorithm implementation-induced systematic error. The true CBFMEASURED/CBFNO-DISPERSION ratios for short mean transit times (MTT) (normal) and long MTT (infarcted) tissue were similar for both dispersion models evaluated; this was an unanticipated result. The CBF quantification inaccuracies induced through the dispersion model truly related to ATD were lower than for the local stenosis-based dispersion for small ATD values. Conclusion Correcting the systematic error present in a previous deconvolution study removes the reported ATD-related impact on CBF quantification. The impact of dispersion was smaller than half that reported in previous simulation studies. J. Magn. Reson. Imaging 2007;25:639–643.

22 July 2022 in NeuroImage
Verified
Journal Article
Open access
MSMarina Salluzzi
Marina Salluzzi
CMCheryl R. McCreary
Cheryl R. McCreary
DGDavid G. Gobbi
David G. Gobbi
MLMichel Louis Lauzon
Michel Louis Lauzon
RFRichard Frayne
Richard Frayne
Quantitative imaging biomarkers (QIBs) can be defined as objective measures that are sensitive and specific to changes in tissue physiology. Provided the acquired QIBs are not affected by scanner changes, they could play an important role in disease diagnosis, prognosis, management, and treatment monitoring. The precision of selected QIBs was assessed from data collected on a 3-T scanner in four healthy participants over a 5-year period. Inevitable scanner changes and acquisition protocol revisions occurred during this time. Standard and custom processing pipelines were used to calculate regional brain volume, cortical thickness, T2, T2*, quantitative susceptibility, cerebral blood flow, axial, radial and mean diffusivity, peak width of skeletonized mean diffusivity, and fractional anisotropy from the acquired images. Coefficient of variation (CoV) and intra-class correlation (ICC) indices were determined in the short-term (i.e., repeatable over three acquisitions within 4 weeks) and in the long-term (i.e., reproducible over four acquisition sessions in 5 years). Precision indices varied based on acquisition technique, processing pipeline, and anatomical region. Good repeatability (average CoV=2.40% and ICC=0.78) and reproducibility (average CoV=8.86 % and ICC=0.72) were found over all QIBs. The best performance indices were obtained for diffusion derived biomarkers (CoV∼0.96% and ICCs=0.87); conversely, the poorest indices were found for the cerebral blood flow biomarker (CoV>10% and ICC<0.5). These results demonstrate that changes in protocol, along with hardware and software upgrades, did not affect the estimates of the selected biomarkers and their precision. Further characterization of the QIB is necessary to understand meaningful changes in the biomarkers in longitudinal studies of normal brain aging and translation to clinical research.



3 March 2020 in medRxiv
Verified
Preprint
Open access
PDF file
CMCheryl R McCreary
Cheryl R McCreary
MSMarina Salluzzi
Marina Salluzzi
LALinda B Andersen
Linda B Andersen
DGDavid Gobbi
David Gobbi
MLM Louis Lauzon
M Louis Lauzon
RFRichard Frayne
Richard Frayne
Introduction: A number of magnetic resonance (MR) imaging methods have been proposed to be useful, quantitative biomarkers of neurodegeneration in aging. The Calgary Normative Study (CNS) is an ongoing single-centre, prospective, longitudinal study that seeks to develop, test and assess quantitative MR methods as potential biomarkers. The CNS has three objectives: first and foremost, to evaluate and characterize the dependence of the selected quantitative neuroimaging biomarkers on age over the adult lifespan; secondly, to evaluate the precision, variability and repeatability of quantitative neuroimaging biomarkers as part of biomarker validation providing proof of-concept and proof-of-principle; and thirdly, provide a shared repository of normative data for comparison to various disease cohorts. Methods and Analysis: Quantitative MR mapping of the brain including longitudinal relaxation time (T1), transverse relaxation time (T2), T2*, magnetic susceptibility (QSM), diffusion and perfusion measurements, as well as morphological assessments are performed. The Montreal Cognitive Assessment (MoCA) and a brief, self-report medical history will be collected. Mixed regression models will be used to characterize changes in quantitative MR biomarker measures over the adult lifespan. In this report on study design, we report interim prevalence and demographic information of recruitment from 28 May 2013 to 31 December 2018. Ethics and Dissemination: Participants provide signed informed consent. Changes in quantitative MR biomarkers measured over the adult lifespan as well as estimates of measurement variance and repeatability will be disseminated through peer-reviewed scientific publication. STRENGTHS AND LIMITATIONS: Both cross-sectional and longitudinal quantitative MR data is being acquired in a large sample normal aging population to characterize changes in these potential neuroimaging biomarkers over the adult lifespan. Clinical and multiple quantitative imaging data are being collected and shared with the research community. Measures of repeatability and a process to update the imaging protocol are included in the study design. Associated self-reported medical history and cognitive assessments are limited